Astrazeneca Pharma India Achieves All-Time High Stock Price Amid Strong Performance

Astrazeneca Pharma India has made headlines today as its stock price reached an all-time high of Rs. 9049.95, marking a significant milestone for the company. This achievement comes amid a strong performance, with the stock outperforming its sector by 5.66%. Over the past three days, Astrazeneca Pharma India has shown impressive momentum, gaining 14.17% in returns.
The stock's volatility has been notable, with an intraday volatility of 22.27%. Astrazeneca Pharma India is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust technical position. In terms of performance metrics, the company has delivered a remarkable 72.86% return over the past year, significantly outpacing the BSE 500 index.

Financially, Astrazeneca Pharma India reported a record net sales figure of Rs. 440.29 crore and an operating profit margin of 17.49%. With a high return on equity of 19.06% and a low debt-to-equity ratio, the company demonstrates strong management efficiency. As it continues to solidify its position in the pharmaceuticals and drugs industry, Astrazeneca Pharma India remains a noteworthy player in the market.